Australia markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
51.64+0.02 (+0.04%)
At close: 04:00PM EDT
51.62 -0.02 (-0.04%)
After hours: 07:52PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-133,094
-131,755
-55,356
-55,489
-37,966
Depreciation & amortisation
4,060
3,139
797
1,642
512
Stock-based compensation
32,470
30,692
22,912
11,638
10,833
Change in working capital
37,924
16,371
-52,956
-26,415
44,128
Accounts receivable
-4,775
-285
7
1,882
49,032
Inventory
-5,474
-851
-
-
-
Accounts payable
820
2,610
2,982
188
-434
Other working capital
-58,969
-94,641
-96,552
-70,913
15,598
Other non-cash items
5,142
5,932
3,460
-1,499
-1,071
Net cash provided by operating activities
-53,498
-75,621
-81,143
-70,123
16,436
Cash flows from investing activities
Investments in property, plant and equipment
-5,471
-19,020
-15,409
-790
-838
Purchases of investments
-235,262
-307,449
-445,671
-211,973
-192,480
Sales/maturities of investments
253,261
418,688
178,720
200,237
140,250
Net cash used for investing activities
12,528
92,219
-282,360
-12,526
-53,068
Cash flows from financing activities
Debt repayment
-
-1,049
-
-
-
Common stock issued
-
0
325,654
73,276
0
Other financing activities
-3,126
-5,273
-3,709
-1,313
-678
Net cash used provided by (used for) financing activities
8,161
1,083
356,621
94,820
24,700
Net change in cash
-32,809
17,681
-6,882
12,171
-11,932
Cash at beginning of period
78,285
33,377
40,259
28,088
40,020
Cash at end of period
45,476
51,058
33,377
40,259
28,088
Free cash flow
Operating cash flow
-53,498
-75,621
-81,143
-70,123
16,436
Capital expenditure
-5,471
-19,020
-15,409
-790
-838
Free cash flow
-58,969
-94,641
-96,552
-70,913
15,598